Skip to main content

Dr. Sunkersett is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sunkersett's full profile

Already have an account?

  • Office

    601 5th St S
    Ste 302
    Saint Petersburg, FL 33701
    Phone+1 727-767-4176
    Fax+1 727-767-4379

Education & Training

  • University of California (San Francisco) School of Medicine
    University of California (San Francisco) School of MedicineFellowship, Blood & Bone Marrow Transplant, 2016 - 2017
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2013 - 2016
  • Nicklaus Children's Hospital
    Nicklaus Children's HospitalResidency, Pediatrics, 2010 - 2013
  • Nova Southeastern University College of Osteopathic Medicine
    Nova Southeastern University College of Osteopathic MedicineClass of 2010

Certifications & Licensure

  • FL State Medical License
    FL State License 2017 - 2026
  • CA State Medical License
    CA State License 2016 - 2018
  • TX State Medical License
    TX State License 2013 - 2017
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Press Mentions

  • The U.S. Food and Drug Administration Approved the Use of IMBRUVICA for the Treatment of Pediatric Patients One Year and Older with cGVHD After Failure of One or More Lines of Systemic Therapy
    The U.S. Food and Drug Administration Approved the Use of IMBRUVICA for the Treatment of Pediatric Patients One Year and Older with cGVHD After Failure of One or More Lines of Systemic TherapyAugust 24th, 2022